麻豆女优

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 麻豆女优 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Community Health Workers
  • Rural Health Payout
  • Measles Outbreaks
  • Doctors’ Liability Premiums
  • Florida鈥檚 KidCare

TRENDING TOPICS:

  • Community Health Workers
  • Rural Health Payout
  • Measles Outbreaks
  • Doctors' Liability Premiums
  • Florida鈥檚 KidCare

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Aug 16 2016

Full Issue

When It Comes To Cosmetic Products' Safety, FDA's Hands Are Tied. Some Want To Change That.

A hair care product that consumers claim has caused hair loss is at the center of a battle that's been brewing over how much the government should be able to regulate cosmetic products. Right now, they can't do much, even if someone dies. But advocates are moving to increase the Food and Drug Administration's power.

When the Los Angeles hairstylist Chaz Dean pitched his almond mint and lavender-scented hair care products 鈥 endorsed by celebrities like Brooke Shields and Alyssa Milano 鈥 he sold millions. But his formula got an unexpected result: itching, rashes, even hair loss in large clumps, in both adults and children. More than 21,000 complaints have been lodged against his Wen Hair Care, and Mr. Dean, the blue-eyed, golden-haired stylist to the stars, has found himself at the center of a fierce debate over the government鈥檚 power to ensure the safety of a cosmetics industry with about $50 billion in annual sales. (Lipton and Abrams, 8/15)

In other FDA news聽鈥

Yet the legal challenge is not over for Medtronic. The company, one of the world鈥檚 largest medical device manufacturers, now faces a whistleblower lawsuit that claims it sought Food and Drug Administration approval for its devices under false pretenses 鈥 and that the devices have been regularly used for a purpose that was never intended by regulators. 鈥淭hey were labeled, 鈥榥ot for cervical spine use,鈥 and yet in everything about them, including emails from their marketing folks, it makes clear that they were meant to be and were used in the cervical spine,鈥 said Dr. Vikas Saini, president of the Lown Institute, a Boston health care think tank, who has followed the case. (Kaplan, 8/15)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 麻豆女优